Single-Cell Genome Sequencing (SCGS) Market 2031
The Single-Cell Genome Sequencing (SCGS) Market is expected to register a CAGR of 15.7% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Single-Cell Genome Sequencing (SCGS) Market report covers analysis By Product (Instruments and Reagents); Technology(Multiple Displacement Amplification (MDA), Microarray, Polymerase Chain Reaction (PCR), Quantitative PCR (qPCR), and Sequencing); Workflow (Genomic Analysis, Sample Preparation and Single Cell Isolation); Disease Indication (Cancer, Immunology, Microbiology, Neurobiology, Prenatal Diagnosis, and Other Diseases); Application (Cell Differentiation/Reprogramming, Circulating Cells, Genomic Variation, Subpopulation Characterization, and Other Applications); and End User (Academic & Research Laboratories, Biotechnology & Biopharmaceutical Companies, Clinics, and Other End Users). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Single-Cell Genome Sequencing (SCGS) Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Single-Cell Genome Sequencing (SCGS) Market Segmentation
Product- Instruments
- Reagents
- Multiple Displacement Amplification
- Microarray
- Polymerase Chain Reaction
- Quantitative PCR
- Sequencing
- Genomic Analysis
- Sample Preparation
- Single Cell Isolation
- Cancer
- Immunology
- Microbiology
- Neurobiology
- Prenatal Diagnosis
- Other Diseases
- Cell Differentiation/Reprogramming
- Circulating Cells
- Genomic Variation
- Subpopulation Characterization
- Other Applications
Strategic Insights
Single-Cell Genome Sequencing (SCGS) Market Growth Drivers- Focus on Precision Medicine: The rising demand for precision medicine drives the adoption of single-cell genome sequencing (SCGS), enabling more precise treatment of complex diseases and expanding the market size.
- Advancements in Sequencing Technologies: Innovations in microfluidics, library preparation, and bioinformatics have reduced costs and improved data quality, fueling market growth. These developments support PEST analysis and market research for SCGS solutions.
- Cancer Research and Development: SCGS plays a crucial role in oncology research, particularly in identifying heterogeneity and clonal evolution. Increased investments in cancer research and growing collaborations strengthen market competitiveness.
- Single-Cell Sequencing in Cancer Research: Single-cell sequencing is vital for high-resolution tumor heterogeneity profiling in cancer research. Key players are collaborating to accelerate research, with innovative partnerships being a core market strategy. SWOT analysis shows market strength but highlights concerns over data complexity. Market forecasts predict growth driven by precision medicine and personalized treatment approaches.
- Advances in SCGS Technologies: SCGS technologies are rapidly improving in data accuracy and processing speed. Major players are investing in R&D to expand product portfolios, fueling adoption. Market trends focus on high-resolution, cost-effective solutions. SWOT analysis points to growth potential through expanded applications, but high costs and regulatory challenges remain risks. Product differentiation and collaboration are major market strengths.
- Single-Cell Sequencing in Developmental Biology: The increasing use of single-cell sequencing in mapping cell differentiation and tissue development is driving demand in developmental biology research. Investment trends indicate rising spending in research institutes and biotech startups. Strategic alliances are a key strategy for innovation. SWOT analysis shows opportunities for scientific breakthroughs, but market sensitivity to funding fluctuations could affect stability and forecasts.
- Research and Academia Demand: Universities and research institutions represent the largest growth potential for SCGS, as they require this technology to gain deeper insights into cellular mechanisms, increasing the market’s relevance.
- Pharmaceutical Revolution: SCGS is transforming the pharmaceutical landscape by supporting personalized medicine and drug efficacy studies. This includes the development of industry partnerships that drive breakthroughs in treatment delivery.
- Single-Cell Sequencing in Oncology: Profiling individual cells through SCGS can accelerate advanced cancer treatment. Companies focusing on developing SCGS platforms for oncology can establish leadership and capture a growing share of the North American market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Single-Cell Genome Sequencing (SCGS) Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Single-Cell Genome Sequencing (SCGS) Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies of this market are: 10x Genomics, BD, BGI, Bio-Rad Laboratories, Inc., Fluidigm, Novogene Corporation, Oxford Nanopore Technologies, QIAGEN, Takara Bio Inc.
Key future trends in this market are - Adoption in Cancer Research, Technological Advancements in Sequencing Platforms, Rising Interest in Developmental Biology
The Single-Cell Genome Sequencing (SCGS) Market is estimated to witness a CAGR of 15.7% from 2023 to 2031.
The major factors driving the Market are: Precision medicine focus, Advancements in sequencing technologies, Cancer research and development
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Single-Cell Genome Sequencing (SCGS) Market - By Product
1.3.2 Single-Cell Genome Sequencing (SCGS) Market - By Technology
1.3.3 Single-Cell Genome Sequencing (SCGS) Market - By Workflow
1.3.4 Single-Cell Genome Sequencing (SCGS) Market - By Disease Indication
1.3.5 Single-Cell Genome Sequencing (SCGS) Market - By Application
1.3.6 Single-Cell Genome Sequencing (SCGS) Market - By End User
1.3.7 Single-Cell Genome Sequencing (SCGS) Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - GLOBAL MARKET ANALYSIS
6.1. SINGLE-CELL GENOME SEQUENCING (SCGS) - GLOBAL MARKET OVERVIEW
6.2. SINGLE-CELL GENOME SEQUENCING (SCGS) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. REAGENTS
7.4.1. Overview
7.4.2. Reagents Market Forecast and Analysis
8. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MULTIPLE DISPLACEMENT AMPLIFICATION (MDA)
8.3.1. Overview
8.3.2. Multiple Displacement Amplification (MDA) Market Forecast and Analysis
8.4. MICROARRAY
8.4.1. Overview
8.4.2. Microarray Market Forecast and Analysis
8.5. POLYMERASE CHAIN REACTION (PCR)
8.5.1. Overview
8.5.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
8.6. QUANTITATIVE PCR (QPCR)
8.6.1. Overview
8.6.2. Quantitative PCR (qPCR) Market Forecast and Analysis
8.7. SEQUENCING
8.7.1. Overview
8.7.2. Sequencing Market Forecast and Analysis
9. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – WORKFLOW
9.1. OVERVIEW
9.2. WORKFLOW MARKET FORECASTS AND ANALYSIS
9.3. GENOMIC ANALYSIS
9.3.1. Overview
9.3.2. Genomic Analysis Market Forecast and Analysis
9.4. SAMPLE PREPARATION
9.4.1. Overview
9.4.2. Sample Preparation Market Forecast and Analysis
9.5. SINGLE CELL ISOLATION
9.5.1. Overview
9.5.2. Single Cell Isolation Market Forecast and Analysis
10. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – DISEASE INDICATION
10.1. OVERVIEW
10.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.4. IMMUNOLOGY
10.4.1. Overview
10.4.2. Immunology Market Forecast and Analysis
10.5. MICROBIOLOGY
10.5.1. Overview
10.5.2. Microbiology Market Forecast and Analysis
10.6. NEUROBIOLOGY
10.6.1. Overview
10.6.2. Neurobiology Market Forecast and Analysis
10.7. PRENATAL DIAGNOSIS
10.7.1. Overview
10.7.2. Prenatal diagnosis Market Forecast and Analysis
10.8. OTHER DISEASES
10.8.1. Overview
10.8.2. Other Diseases Market Forecast and Analysis
11. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATION
11.1. OVERVIEW
11.2. APPLICATION MARKET FORECASTS AND ANALYSIS
11.3. CELL DIFFERENTIATION/REPROGRAMMING
11.3.1. Overview
11.3.2. Cell Differentiation/Reprogramming Market Forecast and Analysis
11.4. CIRCULATING CELLS
11.4.1. Overview
11.4.2. Circulating Cells Market Forecast and Analysis
11.5. GENOMIC VARIATION
11.5.1. Overview
11.5.2. Genomic Variation Market Forecast and Analysis
11.6. SUBPOPULATION CHARACTERIZATION
11.6.1. Overview
11.6.2. Subpopulation Characterization Market Forecast and Analysis
11.7. OTHER APPLICATIONS
11.7.1. Overview
11.7.2. Other Applications Market Forecast and Analysis
12. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET - REVENUE AND FORECASTS TO 2028 – END USER
12.1. OVERVIEW
12.2. END USER MARKET FORECASTS AND ANALYSIS
12.3. ACADEMIC & RESEARCH LABORATORIES
12.3.1. Overview
12.3.2. Academic & Research Laboratories Market Forecast and Analysis
12.4. BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
12.4.1. Overview
12.4.2. Biotechnology & Biopharmaceutical Companies Market Forecast and Analysis
12.5. CLINICS
12.5.1. Overview
12.5.2. Clinics Market Forecast and Analysis
12.6. OTHER END USERS
12.6.1. Overview
12.6.2. Other End Users Market Forecast and Analysis
13. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Single-Cell Genome Sequencing (SCGS) Market Overview
13.1.2 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.1.3 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.1.4 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.1.5 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.1.6 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.1.7 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.1.8 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.1.9 North America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.1.9.1 United States Single-Cell Genome Sequencing (SCGS) Market
13.1.9.1.1 United States Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.1.2 United States Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.1.3 United States Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.1.4 United States Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.1.5 United States Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.1.6 United States Single-Cell Genome Sequencing (SCGS) Market by End User
13.1.9.2 Canada Single-Cell Genome Sequencing (SCGS) Market
13.1.9.2.1 Canada Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.2.2 Canada Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.2.3 Canada Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.2.4 Canada Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.2.5 Canada Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.2.6 Canada Single-Cell Genome Sequencing (SCGS) Market by End User
13.1.9.3 Mexico Single-Cell Genome Sequencing (SCGS) Market
13.1.9.3.1 Mexico Single-Cell Genome Sequencing (SCGS) Market by Product
13.1.9.3.2 Mexico Single-Cell Genome Sequencing (SCGS) Market by Technology
13.1.9.3.3 Mexico Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.1.9.3.4 Mexico Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.1.9.3.5 Mexico Single-Cell Genome Sequencing (SCGS) Market by Application
13.1.9.3.6 Mexico Single-Cell Genome Sequencing (SCGS) Market by End User
13.2. EUROPE
13.2.1 Europe Single-Cell Genome Sequencing (SCGS) Market Overview
13.2.2 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.2.3 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.2.4 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.2.5 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.2.6 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.2.7 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.2.8 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.2.9 Europe Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Single-Cell Genome Sequencing (SCGS) Market
13.2.9.1.1 Germany Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.1.2 Germany Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.1.3 Germany Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.1.4 Germany Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.1.5 Germany Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.1.6 Germany Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.2 France Single-Cell Genome Sequencing (SCGS) Market
13.2.9.2.1 France Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.2.2 France Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.2.3 France Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.2.4 France Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.2.5 France Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.2.6 France Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.3 Italy Single-Cell Genome Sequencing (SCGS) Market
13.2.9.3.1 Italy Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.3.2 Italy Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.3.3 Italy Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.3.4 Italy Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.3.5 Italy Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.3.6 Italy Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.4 Spain Single-Cell Genome Sequencing (SCGS) Market
13.2.9.4.1 Spain Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.4.2 Spain Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.4.3 Spain Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.4.4 Spain Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.4.5 Spain Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.4.6 Spain Single-Cell Genome Sequencing (SCGS) Market by End User
13.2.9.5 United Kingdom Single-Cell Genome Sequencing (SCGS) Market
13.2.9.5.1 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Product
13.2.9.5.2 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Technology
13.2.9.5.3 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.2.9.5.4 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.2.9.5.5 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by Application
13.2.9.5.6 United Kingdom Single-Cell Genome Sequencing (SCGS) Market by End User
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Overview
13.3.2 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.3.3 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.3.4 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.3.5 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.3.6 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.3.7 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.3.8 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.3.9 Asia-Pacific Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Single-Cell Genome Sequencing (SCGS) Market
13.3.9.1.1 Australia Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.1.2 Australia Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.1.3 Australia Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.1.4 Australia Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.1.5 Australia Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.1.6 Australia Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.2 China Single-Cell Genome Sequencing (SCGS) Market
13.3.9.2.1 China Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.2.2 China Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.2.3 China Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.2.4 China Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.2.5 China Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.2.6 China Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.3 India Single-Cell Genome Sequencing (SCGS) Market
13.3.9.3.1 India Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.3.2 India Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.3.3 India Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.3.4 India Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.3.5 India Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.3.6 India Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.4 Japan Single-Cell Genome Sequencing (SCGS) Market
13.3.9.4.1 Japan Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.4.2 Japan Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.4.3 Japan Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.4.4 Japan Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.4.5 Japan Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.4.6 Japan Single-Cell Genome Sequencing (SCGS) Market by End User
13.3.9.5 South Korea Single-Cell Genome Sequencing (SCGS) Market
13.3.9.5.1 South Korea Single-Cell Genome Sequencing (SCGS) Market by Product
13.3.9.5.2 South Korea Single-Cell Genome Sequencing (SCGS) Market by Technology
13.3.9.5.3 South Korea Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.3.9.5.4 South Korea Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.3.9.5.5 South Korea Single-Cell Genome Sequencing (SCGS) Market by Application
13.3.9.5.6 South Korea Single-Cell Genome Sequencing (SCGS) Market by End User
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Overview
13.4.2 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.4.3 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.4.4 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.4.5 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.4.6 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.4.7 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.4.8 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.4.9 Middle East and Africa Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Single-Cell Genome Sequencing (SCGS) Market
13.4.9.1.1 South Africa Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.1.2 South Africa Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.1.3 South Africa Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.1.4 South Africa Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.1.5 South Africa Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.1.6 South Africa Single-Cell Genome Sequencing (SCGS) Market by End User
13.4.9.2 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market
13.4.9.2.1 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.2.2 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.2.3 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.2.4 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.2.5 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.2.6 Saudi Arabia Single-Cell Genome Sequencing (SCGS) Market by End User
13.4.9.3 U.A.E Single-Cell Genome Sequencing (SCGS) Market
13.4.9.3.1 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Product
13.4.9.3.2 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Technology
13.4.9.3.3 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.4.9.3.4 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.4.9.3.5 U.A.E Single-Cell Genome Sequencing (SCGS) Market by Application
13.4.9.3.6 U.A.E Single-Cell Genome Sequencing (SCGS) Market by End User
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Single-Cell Genome Sequencing (SCGS) Market Overview
13.5.2 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis
13.5.3 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Product
13.5.4 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Technology
13.5.5 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Workflow
13.5.6 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Disease Indication
13.5.7 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Application
13.5.8 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By End User
13.5.9 South and Central America Single-Cell Genome Sequencing (SCGS) Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Single-Cell Genome Sequencing (SCGS) Market
13.5.9.1.1 Brazil Single-Cell Genome Sequencing (SCGS) Market by Product
13.5.9.1.2 Brazil Single-Cell Genome Sequencing (SCGS) Market by Technology
13.5.9.1.3 Brazil Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.5.9.1.4 Brazil Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.5.9.1.5 Brazil Single-Cell Genome Sequencing (SCGS) Market by Application
13.5.9.1.6 Brazil Single-Cell Genome Sequencing (SCGS) Market by End User
13.5.9.2 Argentina Single-Cell Genome Sequencing (SCGS) Market
13.5.9.2.1 Argentina Single-Cell Genome Sequencing (SCGS) Market by Product
13.5.9.2.2 Argentina Single-Cell Genome Sequencing (SCGS) Market by Technology
13.5.9.2.3 Argentina Single-Cell Genome Sequencing (SCGS) Market by Workflow
13.5.9.2.4 Argentina Single-Cell Genome Sequencing (SCGS) Market by Disease Indication
13.5.9.2.5 Argentina Single-Cell Genome Sequencing (SCGS) Market by Application
13.5.9.2.6 Argentina Single-Cell Genome Sequencing (SCGS) Market by End User
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. SINGLE-CELL GENOME SEQUENCING (SCGS) MARKET, KEY COMPANY PROFILES
15.1. 10X GENOMICS
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. BD
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. BGI
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. BIO-RAD LABORATORIES, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. FLUIDIGM
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. NOVOGENE CORPORATION
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. OXFORD NANOPORE TECHNOLOGIES
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. QIAGEN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. TAKARA BIO INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. THERMO FISHER SCIENTIFIC INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. 10x Genomics2. BD3. BGI4. Bio-Rad Laboratories, Inc.5. Fluidigm6. Novogene Corporation7. Oxford Nanopore Technologies8. QIAGEN9. Takara Bio Inc.10. Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For